The reason is obvious: If Medicare can bargain on behalf of 40 million Medicare recipients, it has the bargaining power to bring down the cost of drugs for seniors. The pharmaceutical companies hate that concept, ``like the devil hates holy water,'' to quote our old friend Senator Bumpers, who used to say that on the floor from time to time. They don't want competition. They don't want cost control. They have won the day. They are spending millions of dollars saying vote for this bill because this bill will mean millions and millions more in profit for those same pharmaceutical companies.
Editor's note · Context
Discussing the need for Medicare to negotiate drug prices during a debate on prescription drug coverage.
Share
More from Dick Durbin
Yesterday’s Supreme Court order is a temporary procedural win for President Trump as he attempts to pursue these lawless goals—but it doesn’t change the reality that the Constitution empowers states to run our elections, and the rule of…
The Trump administration has not provided transparency into the use of federal funds for the East Wing project, and they have limited congressional oversight, meaningful public input, and adherence to established federal processes.
What I witnessed today illustrated President Trump and Stephen Miller’s ruthless agenda: they will go so far with their cruel immigration operation to target terrified children, forcing them to articulate their fears in front of a judge…
We want to be clear: Democrats and Republicans did not work together to appropriate funds for AHRQ as a gentle suggestion for the Department to follow at their discretion or leisure.





